Jill Macoska

15PUBLICATIONS
31CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Molecular targetsLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 08, 2024
FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer.

Zifeng Wang, Scott L Townley, Songqi Zhang

|Dec 14, 2023
A Bayesian noisy logic model for inference of transcription factor activity from single cell and bulk transcriptomic data.

Argenis Arriojas, Susan Patalano, Jill Macoska

|Sep 04, 2023
Demethylation of EHMT1/GLP Protein Reprograms Its Transcriptional Activity and Promotes Prostate Cancer Progression.

Anna Besschetnova, Wanting Han, Mingyu Liu

|Aug 07, 2023
SETD7 functions as a transcription repressor in prostate cancer via methylating FOXA1.

Zifeng Wang, Jessica Petricca, Mingyu Liu

Pageof 3